CoChat

Association Between Clinician Computer Use and Communication With Patients in Safety-Net Clinics

Open access
Ratanawongsa, Neda, Barton, Jennifer L., Lyles, Courtney R., Wu, Michael, Yelin, Edward H., Martinez, Diana, Schillinger, Dean · 2016 · JAMA Internal Medicine
Cited by 86

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Abstract

issue guidelines on the inclusion of women in clinical trials.6 Given that KD is highly prevalent and may modify relevant parameters of some medications or procedures (eg, efficacy, safety, and pharmacokinetics), patients with KD should be included in cardiovascular trials in the absence of absolute contraindications.Investigators' goal should be to enroll a study population in which the prevalence and severity of KD match the prevalence and severity in the target population.Furthermore, investigators should consider stratifying treatment assignment based on kidney function to achieve balance and should report outcome and safety results stratified by level of baseline kidney function.What does widespread exclusion of patients with KD from cardiovascular trials mean for the practicing internist or nephrologist who must manage CVD in patients with KD? Unfortunately, the currently available randomized clinical trial data on the efficacy and safety of cardiovascular interventions in patients with KD is insufficient to make recommendations on the optimal approach for many therapies.This report underscores the need for greater inclusion of patients with KD in cardiovascular trials or the design of trials specifically focused on this population to better characterize the risks and benefits of cardiovascular interventions in this highly prevalent and prognostically important subgroup of patients.The number of randomized clinical trials within the field of nephrology is low, and the trials are of poor quality and are unlikely to provide adequate data on the treatment of CVD in patients with KD. 2 Extrapolation of trial results conducted in the general population to patients with KD may or may not be appropriate, and a deeper understanding of the barriers to including patients with KD in cardiovascular trials and the development of strategies to overcome them is urgently needed.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1001/jamainternmed.2015.6186

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 1 references

Cited by

See all 86

Metadata

Authors
Ratanawongsa, N., Barton, J. L., Lyles, C. R., Wu, M., Yelin, E. H., Martinez, D., & Schillinger, D.
Venue
JAMA Internal Medicine
Published
2016-01-01
Volume
176
Issue
1
Pages
125
ISSN
2168-6106 (ISSN-L)
OpenAlex
W2188041332
Cited by
86
References
1
FWCI
18.13
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Association Between Clinician Computer Use and Communication With Patients in Safety-Net Clinics. https://app.cochat.ai/papers/10.1001/jamainternmed.2015.6186
The paper
Ratanawongsa, N., Barton, J. L., Lyles, C. R., Wu, M., Yelin, E. H., Martinez, D., & Schillinger, D. (2016). Association Between Clinician Computer Use and Communication With Patients in Safety-Net Clinics. JAMA Internal Medicine. https://doi.org/10.1001/jamainternmed.2015.6186

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.